# US 2026/0096759 A1 · System and method for neuromonitoring based on a biosignal

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0096759 A1
- Document ID: US20260096759A1
- Status: Published application
- Kind: A1
- Application number: 19/114,904
- Filed: 2022-09-27
- Published: 2026-04-09
- Earliest claimed: 2022-09-27
- Assignees: Dr. Langer Medical GmbH
- Applicants: Dr. Langer Medical GmbH
- Inventors: Ramona SCHULER
- Web page: https://patentgrep.com/patent/US20260096759A1

## CPC

- A61B 5/205: {Determining bladder or urethral pressure}
- A61B 5/053: Measuring electrical impedance or conductance of a portion of the body
- A61B 5/1107: {Measuring contraction of parts of the body, e.g. organ or muscle}
- A61B 5/4035: {Evaluating the autonomic nervous system}
- A61B 5/4893: {Nerves}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Provided is a medical system and method for neuromonitoring based on a biosignal. The medical system includes a computing system and performs the method for neuromonitoring based on a biosignal. The method includes monitoring and analysing the biosignal for localizing autonomic nerves associated with a stimulus-induced muscle reaction of smooth muscles of a target organ. The analysing step includes performing time-domain signal analysis of the biosignal to obtain time-domain signal characteristics; performing time-frequency-domain signal analysis of the biosignal to obtain time-frequency-domain signal characteristics; and determining, based on the time-domain signal characteristics and the time-frequency-domain signal characteristics, whether the biosignal is representative of a stimulus-induced muscle reaction. The method further includes outputting an indication that the stimulus-induced muscle reaction has been detected based on determining that the biosignal is representative of the stimulus-induced muscle reaction.

## Claims

### Claim 1

A method for neuromonitoring based on a biosignal, the method comprising:
monitoring and analysing the biosignal for localizing autonomic nerves associated with a stimulus-induced muscle reaction of smooth muscles of a target organ, by:
performing time-domain signal analysis of the biosignal to obtain one or more time-domain signal characteristics, the biosignal based on measurement data obtained by a neuromonitoring device;
performing time-frequency-domain signal analysis of the biosignal to obtain one or more time-frequency-domain signal characteristics; and
determining, based on the time-domain signal characteristics and the time-frequency-domain signal characteristics-determining, the biosignal is representative of the stimulus-induced muscle reaction; and
outputting an indication that the stimulus-induced muscle reaction has been detected based on determining that the biosignal is representative of the stimulus-induced muscle reaction.

### Claim 2 (depends on 1)

The method of claim 1, further comprising:
based on the time-domain signal characteristics and the time-frequency-domain signal characteristics, distinguishing between features in the biosignal that are representative of artifacts and features in the biosignal that are representative of the stimulus-induced muscle reaction, and
optionally, distinguishing between features in the biosignal that are not representative of a significant biosignal response.

### Claim 3 (depends on 1)

The method of claim 1, wherein the obtained one or more time-domain signal characteristics comprise at least one of the following:
a maximum amplitude within the biosignal relative to a base-level of the biosignal, the biosignal being a waveform,
an onset latency of a transient signal change within the biosignal,
a gradient of a transient signal change within the biosignal,
a time to reach maximum gradient of a transient signal change within the biosignal,
a duration of a transient signal change within the biosignal from an onset of the transient signal change, and/or
regression coefficients.

### Claim 4 (depends on 1)

The method of claim 1, wherein the obtained one or more time-frequency-domain signal characteristics comprise a magnitude of transformation coefficients.

### Claim 5 (depends on 1)

The method of claim 1, wherein the performing the time-frequency-domain signal analysis comprises:
transforming the biosignal or a first derivative of the biosignal to the time-frequency-domain; and
analysing one or more transformation coefficients,
optionally, the analysing comprises analysing one or more transformation coefficients of a Wavelet Transform (WT) or of a Short-Time Fourier Transform (STFT).

### Claim 6

(canceled)

### Claim 7 (depends on 5)

The method of claim 5, wherein the performing the time-frequency-domain signal analysis comprises:
selecting a window function and scaling the window function;
obtaining, for each of a plurality of samples, one or more transformation coefficients; and
analysing at least a subset of the one or more transformation coefficients.

### Claim 8 (depends on 5)

The method of claim 5, wherein the analysing the one or more transformation coefficients comprises:
representing a magnitude of one or more of the transformation coefficients as a function of time and frequency;
identifying candidate features in the function; and
determining, for at least one of the identified candidate features, the candidate feature is representative of the stimulus-induced muscle reaction, the determining based on one or more of the time-domain signal characteristics and/or based on one or more of the time-frequency-domain signal characteristics.

### Claim 9 (depends on 5)

The method of claim 5, wherein the performing the time-frequency-domain signal analysis comprises analysing the one or more transformation coefficients taking into account the one or more time-domain signal characteristics and/or information derived from the one or more time-domain signal characteristics.

### Claim 10 (depends on 8)

The method of claim 8, wherein the performing the time-frequency-domain signal analysis comprises:
determining a time frame corresponding to a selected portion; and
determining whether a candidate feature is representative of the stimulus-induced muscle reaction at least based on the determined time frame.

### Claim 11 (depends on 1)

The method of claim 1, the method comprising any one of the following:
performing a Continuous Wavelet Transform (CWT) of the biosignal or a first derivative of the biosignal, or
performing a Discrete Wavelet Transform (DWT) of the biosignal or a first derivative of the biosignal, or
performing a Short-Time Fourier Transform (STFT) of the biosignal or a first derivative of the biosignal.

### Claim 12 (depends on 1)

The method of claim 1, wherein the monitoring and analysing of the biosignal is triggered by receiving an indication of a stimulus being applied to a tissue, and/or wherein the time-domain signal analysis and/or the time-frequency-domain signal analysis are based on one or more characteristics of the stimulus being applied to the tissue.

### Claim 13 (depends on 1)

The method of claim 1, further comprising:
pre-processing an output signal of the neuromonitoring device to obtain the biosignal, the pre-processing comprising any one or more of the following:
normalizing the output signal with respect to a base-level of the biosignal,
applying a low pass filter, and/or
performing a sweep extraction.

### Claim 14 (depends on 1)

The method of claim 1, further comprising:
integrating and/or differentiating the biosignal, wherein results of the integrating and/or the differentiating are used as input for the time-domain signal analysis and/or for the time-frequency-domain signal analysis.

### Claim 15 (depends on 14)

The method of claim 14, comprising:
performing continuously or for each of a plurality of sweeps of the biosignal, the time-domain signal analysis and the time-frequency-domain signal analysis, and
optionally, performing continuously or for each of a plurality of sweeps of the biosignal, the integrating and/or the differentiating of the biosignal.

### Claim 16

(canceled)

### Claim 17 (depends on 1)

The method of claim 1, wherein the biosignal is an impedance signal or a bladder pressure signal, and/or wherein the stimulus-induced muscle reaction is a muscle contraction.

### Claim 18

(canceled)

### Claim 19 (depends on 1)

The method of claim 1, further comprising:
acquiring, by the neuromonitoring device, measurement data;
applying a stimulus to a portion of a tissue; and
in response to determining that the biosignal is representative of the stimulus-induced muscle reaction caused by applying the stimulus to the portion of the tissue, outputting an indication that the portion of the tissue comprises nerves associated with the smooth muscles.

### Claim 20 (depends on 1)

The method of claim 1, further comprising:
performing the monitoring and analysing and the outputting steps for at least two biosignals, the biosignals obtained for different target organs for localizing autonomic nerves associated with the stimulus-induced muscle reaction of smooth muscles of each of the different target organs.

### Claim 21

A medical system, comprising:
a computing system, the computing system comprising:
at least one computer comprising a non-transitory memory device and at least one processor configured to communicate with the non-transitory memory device, the non-transitory memory device storing a computer program comprising executable instructions that, when executed on the at least one processor of the at least one computer or loaded onto the at least one processor of the at least one computer, cause the at least one computer to perform a method for neuromonitoring based on a biosignal by:
monitoring and analysing the biosignal for localizing autonomic nerves associated with a stimulus-induced muscle reaction of smooth muscles of a target organ, by:
performing time-domain signal analysis of the biosignal to obtain one or more time-domain signal characteristics, the biosignal based on measurement data obtained by a neuromonitoring device;
performing time-frequency-domain signal analysis of the biosignal to obtain one or more time-frequency-domain signal characteristics; and
determining, based on the time-domain signal characteristics and time-frequency-domain signal characteristics, the biosignal representative of the stimulus-induced muscle reaction; and
outputting an indication that the stimulus-induced muscle reaction has been detected based on determining that the biosignal is representative of the stimulus-induced muscle reaction.

### Claim 22 (depends on 21)

The medical system of claim 21, further comprising:
a device operatively connected to the computing system and configured to apply a stimulus to a portion of a tissue, and optionally, the device is configured to provide, to the computing system, information indicating timing and/or characteristics of the stimulus being applied; and/or
the neuromonitoring device operatively connected to the computing system and configured to acquire the measurement data; and/or
wherein the outputting comprises outputting, by an output device of the computing system, the indication that the stimulus-induced muscle reaction has been detected, and optionally, wherein the output device comprises at least one of a visual output device, an audio output device, or a haptic output.

### Claim 23

(canceled)

### Claim 24

A non-transitory computer-readable storage medium storing a computer program comprising program instructions that, when executed on at least one processor of a computer or loaded onto the at least one processor of the computer, cause the computer to perform a method for neuromonitoring based on a biosignal by:
monitoring and analysing the biosignal for localizing autonomic nerves associated with a stimulus-induced muscle reaction of smooth muscles of a target organ, by:
performing time-domain signal analysis of the biosignal to obtain one or more time-domain signal characteristics, the biosignal based on measurement data obtained by a neuromonitoring device;
performing time-frequency-domain signal analysis of the biosignal to obtain one or more time-frequency-domain signal characteristics; and
determining, based on the time-domain signal characteristics and time-frequency-domain signal characteristics, the biosignal is representative of the stimulus-induced muscle reaction; and
outputting an indication that the stimulus-induced muscle reaction has been detected based on determining that the biosignal is representative of the stimulus-induced muscle reaction.
